Invited Commentary: Advanced Anatomic and Molecular Imaging in Recurrent Prostate Cancer.
作者信息
Turkbey Baris
机构信息
From the Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, 10 Center Dr, Room B3B85, Bethesda, MD 20892.
出版信息
Radiographics. 2023 Dec;43(12):e230215. doi: 10.1148/rg.230215.
Abstract
摘要
相似文献
1
Invited Commentary: Advanced Anatomic and Molecular Imaging in Recurrent Prostate Cancer.特邀评论：复发性前列腺癌的高级解剖学和分子成像
Radiographics. 2023 Dec;43(12):e230215. doi: 10.1148/rg.230215.
2
Management of biochemically recurrent prostate cancer: molecular imaging perspective.生化复发前列腺癌的管理：分子影像视角
World J Urol. 2018 Feb;36(2):321-322. doi: 10.1007/s00345-017-2127-0. Epub 2017 Nov 13.
3
Imaging Locally Advanced, Recurrent, and Metastatic Prostate Cancer: A Review.局部晚期、复发性和转移性前列腺癌的影像学诊断：综述。
JAMA Oncol. 2017 Oct 1;3(10):1415-1422. doi: 10.1001/jamaoncol.2016.5840.
4
Clinical Applications of Molecular Imaging in the Management of Prostate Cancer.分子成像在前列腺癌管理中的临床应用
PET Clin. 2017 Apr;12(2):185-192. doi: 10.1016/j.cpet.2016.11.001. Epub 2017 Jan 16.
5
The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer.MRI 在放射性和局部治疗后复发性前列腺癌的检测和分期中的作用。
World J Urol. 2019 Aug;37(8):1485-1490. doi: 10.1007/s00345-019-02677-y. Epub 2019 Feb 20.
6
A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.在复发性前列腺癌检测中从解剖成像向功能和分子成像的范式转变。
Future Oncol. 2014 Feb;10(3):457-74. doi: 10.2217/fon.13.196.
7
Prostate MR Imaging for Posttreatment Evaluation and Recurrence.用于治疗后评估和复发的前列腺磁共振成像
Radiol Clin North Am. 2018 Mar;56(2):263-275. doi: 10.1016/j.rcl.2017.10.008. Epub 2017 Nov 27.
8
Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review.当前前列腺癌复发和转移的影像学检查技术及影像学表现：影像学综述。
Radiographics. 2020 May-Jun;40(3):709-726. doi: 10.1148/rg.2020190121. Epub 2020 Mar 20.
9
Functional and molecular imaging of localized and recurrent prostate cancer.局限性和复发性前列腺癌的功能和分子成像。
Eur J Nucl Med Mol Imaging. 2013 Jul;40 Suppl 1(Suppl 1):S48-59. doi: 10.1007/s00259-013-2419-6. Epub 2013 May 7.
10
[Comments on article "Usefulness of PET scans in diagnosing recurrent prostate cancer. Prostate with PSA level <5"].[关于文章《PET扫描在诊断复发性前列腺癌中的应用。PSA水平<5时的前列腺癌》的评论]
Actas Urol Esp. 2009 Sep;33(8):841. doi: 10.1016/s0210-4806(09)72868-2.
本文引用的文献
1
MRI and PSMA PET/CT of Biochemical Recurrence of Prostate Cancer.磁共振成像和 PSMA PET/CT 对前列腺癌生化复发的诊断。
Radiographics. 2023 Dec;43(12):e230112. doi: 10.1148/rg.230112.
2
Ga-PSMA-11 PET/CT versus Ga-PSMA-11 PET/MRI for the detection of biochemically recurrent prostate cancer: a systematic review and meta-analysis.镓-PSMA-11 PET/CT与镓-PSMA-11 PET/MRI用于检测生化复发前列腺癌的系统评价和荟萃分析
Front Oncol. 2023 Aug 14;13:1216894. doi: 10.3389/fonc.2023.1216894. eCollection 2023.
3
ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update.ACR 适宜性标准®：前列腺癌治疗后随访：2022 年更新。
J Am Coll Radiol. 2023 May;20(5S):S164-S186. doi: 10.1016/j.jacr.2023.02.012.
4
Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis.前列腺癌原发和继发分期中 PSMA-PET/CT 的组织病理学验证诊断准确性及 PSMA-PET/CT 对临床管理的影响：系统评价和荟萃分析。
Semin Nucl Med. 2023 Sep;53(5):706-718. doi: 10.1053/j.semnuclmed.2023.02.006. Epub 2023 Mar 31.
5
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
6
Validation of F-rhPSMA-7 and F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer.F-rhPSMA-7 和 F-rhPSMA-7.3 PET 成像结果与前列腺癌生化复发患者挽救性手术中组织病理学的验证。
J Nucl Med. 2022 Dec;63(12):1809-1814. doi: 10.2967/jnumed.121.263707. Epub 2022 Apr 7.
7
PET Imaging for Prostate Cancer.前列腺癌的正电子发射断层扫描（PET）成像。
Radiol Clin North Am. 2021 Sep;59(5):801-811. doi: 10.1016/j.rcl.2021.05.008.
8
A Comprehensive Assessment of Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients.Ga-PSMA-11 PET 在生化复发前列腺癌中的全面评估：来自 2005 例患者的前瞻性多中心研究结果。
J Nucl Med. 2022 Apr;63(4):567-572. doi: 10.2967/jnumed.121.262412. Epub 2021 Jul 29.
9
Evaluating Biochemically Recurrent Prostate Cancer: Histologic Validation of F-DCFPyL PET/CT with Comparison to Multiparametric MRI.评估生化复发前列腺癌：F-DCFPyL PET/CT 与多参数 MRI 的组织学验证比较。
Radiology. 2020 Sep;296(3):564-572. doi: 10.1148/radiol.2020192018. Epub 2020 Jul 7.
10
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.局限性前列腺癌监测、手术或放疗 10 年后的结果。
N Engl J Med. 2016 Oct 13;375(15):1415-1424. doi: 10.1056/NEJMoa1606220. Epub 2016 Sep 14.
Zotero 插件